Tuesday, March 29, 2022 2:35:47 PM
ReviveThomas.. It's just my opinion, but I provided an estimated overall time line a few months. Based on this new estimate from RVVTF today, and my painful experiences with bitotech and EUA, my new projection is:
- July 1, 2022. Enrollment complete.
- Sep 1, 2022. Finish trial from new enrollments.
- Dec 1, 2022. Collect, organize, study, raw data. Package & sub EUA.
- Mar 1, 2023. FDA reviews and makes a decision on EUA.
This assumes there are no snags (ex: FDA request more data, hence trial is extended, pandemic formally over, etc.)
Unfortunately, this timelines will put downward pressure on the PPS while investors patiently wait. The FDA processes are always slow and painful for investors, unless it is BP. JMHO
- July 1, 2022. Enrollment complete.
- Sep 1, 2022. Finish trial from new enrollments.
- Dec 1, 2022. Collect, organize, study, raw data. Package & sub EUA.
- Mar 1, 2023. FDA reviews and makes a decision on EUA.
This assumes there are no snags (ex: FDA request more data, hence trial is extended, pandemic formally over, etc.)
Unfortunately, this timelines will put downward pressure on the PPS while investors patiently wait. The FDA processes are always slow and painful for investors, unless it is BP. JMHO
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
